How Has the Left Atrial Appendage Closure Device Market Size Evolved in Recent Years?
The left atrial appendage closure device market has seen considerable growth due to a variety of factors.
• The market size for left atrial appendage closure devices has experienced swift expansion in the past few years. The market is expected to increase from $1.67 billion in 2024 to $2 billion in 2025, registering a compound annual growth rate (CAGR) of 19.5%.
The upward trajectory during the historical period can be linked to factors such as the rising incidence of atrial fibrillation, strategies for stroke prevention, strong clinical evidence and research, minimally invasive treatment alternatives, a preference for non-drug options among patients, an aging demographic, and heightened expertise and training among doctors.
What Are The Predictions for The Left Atrial Appendage Closure Device Market in the Coming Years?
The left atrial appendage closure device market is expected to maintain its strong growth trajectory in upcoming years.
• The market for left atrial appendage closure device is set to witness a significant surge in the forthcoming years, expanding to $3.74 billion by 2029 with an impressive compound annual growth rate (CAGR) of 17.0%.
This market growth in the projected timeframe can be correlated with the escalating global impact of atrial fibrillation, special focus on preventing stroke in patients at high risk, enhanced patient consciousness, its incorporation into customary clinical procedures, and worldwide initiatives in handling cardiovascular diseases. The forecasted period will showcase key trends such as the introduction of percutaneous closure methods, innovative device designs, escalating utilisation of imaging technologies, emphasis on less invasive procedures, and personalised device selection based on patient's anatomical considerations.
Which Drivers Are Accelerating Growth In The Left Atrial Appendage Closure Device Market?
The left atrial appendage (LAA) closure device market is set to grow, fueled by an increasing occurrence of atrial fibrillation. This medical issue is characterized by an unstandardized and commonly fast heartbeat caused by the lack of coordinated beating in the heart's upper chambers, the atria. The primary utilization of LAA closure devices is to treat atrial fibrillation, decreasing stroke risk in people with this heart rhythm problem, and averting the formation or escape of blood clots. For instance, in October 2022, data presented by the Centers for Disease Control and Prevention, a US government agency, indicated that atrial fibrillation accounted for over 454,000 annual hospital admissions in the US alone, with projections suggesting that by 2030, 12.1 million Americans will be suffering from it. As such, the increasing instances of atrial fibrillation are set to boost the growth of the LAA closure device market. The exponential increase in the geriatric population also looks set to drive the expansion of the left atrial appendage (LAA) closure device market. This demographic, comprising individuals of 65 years and above, requires health care that focuses on the unique needs and age-related problems of this age group. LAA closure devices are advantageous for this population, reducing the risk of stroke that is associated with atrial fibrillation, a condition common among the elderly. For instance, a report by Eurostat, a European government agency, in August 2023, revealed that more than 21% of the EU population in 2022 was at least 65 years old, with the populace's medium age hitting 44.4 years, indicating that half of the population was older than this. Consequently, the rise in the elderly population is steering the growth of the LAA closure device market.
What Are The Core Segments Of The Global Left Atrial Appendage Closure Device Market?
The left atrial appendage closure device market covered in this report is segmented –
1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices
2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices
Pre-Book The Left Atrial Appendage Closure Device Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Left Atrial Appendage Closure Device Market?
In order to improve non-valvular atrial fibrillation (NVAF) treatment, leading businesses in the left atrial appendage closure device market are producing innovative items like the Watchman FLX. The Watchman FLX pro device, a self-expanding device placed in the LAA to block its opening and avoid clotting, provides patients a different option to oral anticoagulation therapy. Boston Scientific Corporation, a manufacturing company based in the US, got approval for Watchman FLX by the US's Food and Drug Administration in September 2022, intending to reduce the likelihood of stroke for those struggling with NVAF. This version of the Watchman device is designed to be more flexible and easier to implant, making it a more applicable choice for a wider variety of patients. Additionally, it is deemed a safe and effective method to minimize stroke risk in NVAF patients, making it a precious alternative for patients unable to undergo oral anticoagulation therapy or who find it challenging to manage their therapy.
Who Are the Key Players In The Left Atrial Appendage Closure Device Market?
Major companies operating in the left atrial appendage closure device market report are:
• Johnson And Johnson Pvt Ltd.
• Abbott Laboratories
• Medtronic plc.
• Atrium Medical Corporation
• Boston Scientific Corporation
• Gore Medical Inc.
• Lepu Medical Technology Co. Ltd.
• MicroPort Scientific Corporation
• AtriCure Inc.
• Dune Medical Devices Ltd.
• Lifetech Scientific Corporation
• Sahajanand Medical Technologies Limited
• Occlutech
• Cardiva Medical Inc.
• Sentreheart Inc.
• Aegis Medical Group
• Coherex Medical Inc.
• EndoStim Inc.
• Conformal Medical Inc.
• Cardia Inc.
• Medical Device Business Service Inc.
• Protaryx Medical
• Append Medical Ltd.
• Vascular Innovations Co. Ltd.
• Vivasure Medical Inc.
• Atritech Inc.
• CardiaMed AB
• Cardialen Inc.
• Kalila Medical Inc.
What Are The Regional Insights Into The Left Atrial Appendage Closure Device Market?
North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
